BIOLYO - Key Persons
Adam Ostrowski has a Master's degree in Biotechnology and brings 2 years of experience in fermentations and research on probiotics and the impact of human milk oligosaccharides on the gut microbiome. Additionally, Adam also worked in the diagnostics field on PCR analyses for 2 years. At BioLyo, Adam focusses mostly on fermentation optimization.
Joran Bauwens holds a Master of Bioscience Engineering and started to work at BioLyo a year ago. Joran rapidly developed an interest in fermentation, statistics and especially lyophilization.
Julie Valcke joined BioLyo after graduating from her bachelor's education in Biomedical and pharmaceutical techniques. During her internship, she expanded her knowledge with various lab techniques such as PCR and HPLC.
Job Titles:
- Member of the Board
- Founder and CEO of ILiAD Biotechnologies
Keith Rubin, M.D. is Founder and CEO of ILiAD Biotechnologies and serves on the Executive Board. Prior to ILiAD, Dr. Rubin founded Seedlings Life Science Ventures, a medical technology company that has successfully developed and advanced multiple patented technologies including the out-license of IP for a commercialized auto-injector to treat anaphylaxis. From 1990 to 2000, Dr. Rubin practiced Internal Medicine with a primary focus on the care of patients with HIV and AIDS in New York City and served as Teaching Attending at Beth Israel and Cabrini Medical Centers and St. Vincent's Hospital. Dr. Rubin has been Assistant Professor of Clinical Medicine at the University of Miami Miller School of Medicine (UM) and New York Medical College, and has held several positions in technology innovation at UM, including Executive Director of BioScience Ventures. He is a graduate of the University of Miami School of Medicine and holds a B.A. in Biology from Princeton University.
Ken Solovay, Board Member. Ken has 25 years of experience in the healthcare industry, including positions in product development and program management at Johnson & Johnson and C.R. Bard as well as executive management roles at the start-up ventures Aspiration Medical Technology (AMT), GMP Companies and Seedlings Life Science Ventures. As President of AMT, Ken was responsible for bringing an obesity treatment from concept through development and validation in clinical trials, as well as being instrumental in the company completing a $16 million series D capital fundraise that led ultimately to FDA PMA approval. Ken has extensive experience developing implantable devices with minimally invasive delivery systems, and holds 36 US patents. Ken has a M.S. in Biomedical Engineering from the University of Alabama at Birmingham with an expertise in Biomaterials, and a B.S. in Materials Science & Engineering from the University of Florida.
Laura De Clercq has a Bachelor's degree in Biological and Pharmaceutical Laboratory Sciences and gained 4 years of experience as a lab technician working in research centres, performing many techniques including PCR and cell culturing and transfection. Additionally, Laura also has half a year of experience as a QA engineer in a pharmaceutical company. For the last 2 years at BioLyo Laura has been working on fermentations, tangential flow filtration and lyophilization.
Liesbeth Vercruyssen, COO. Making the switch from Academia to Industry in 2016, Liesbeth brings 8 years of experience as Project Leader in the CDMO business. Starting at Q-Biologicals with 25 employees, she guided biologicals projects from the developmental phase to the clinical stages. Liesbeth was responsible for GMP upstream and downstream manufacturing, coordinating with Quality assurance and Quality control and was the first point of contact for clients. She contributed to the successful expansion of a start-up company to a company with over 100 employees as Q-Biologicals was acquired by Amatsigroup and subsequently by Eurofins. Liesbeth received her PhD in Biotechnology in 2012 from Ghent University, Belgium, for her work on molecular mechanisms that govern plant growth at the Flanders Institute of Biotechnology (VIB), where she continued her research as a Post-Doc.
Lizie Fraeyman, Head of BioLyo's GMP certified QC laboratories. Lizie has 12 years experience in various roles in Quality Control, starting as a QC technician and gradually taking on more managerial and validation responsibilities. Due to her diverse experience Lizie has a very pragmatic approach to QC, both from a GMP and ISO perspective. At BioLyo, Lizie has set up the QC laboratory and managed to achieve GMP certification within a year. The QC lab is capable of carrying out GMP stability studies, release testing for IMPs as well developing more complicated (cell based) assays.
Łukasz Wajda obtained his PhD in Food Technology and Nutrition, followed by a 1 year post graduate position in molecular biology. Łukasz has 6 years of experience in R&D of probiotics, including developing of qPCR assays. Łukasz has experience in writing grant applications for development and the implementation of ISO9001 in a diagnostics setting. At BioLyo, Łukasz is one of our experts on statistics and fermentation.
Marcel Thalen is CEO of BioLyo. He has 33 years of experience in process development, manufacturing, and drug development of vaccines and other (live) biologicals. Marcel is an expert in the physiology of bacterial pathogens, exploiting this knowledge to increase the productivity and consistency of manufacturing and thereby the quality of the resulting products. Marcel started his career at the RIVM/Netherlands Vaccine Institute (NVI) where he had increasing responsibilities, advancing to Department Head of Process Development. Subsequently, Marcel became Scientific Officer for SynCo Bio Partners (a leading contract manufacturing organization) where he managed process development and GMP manufacturing projects involving live biologicals including lyophilization development. More recently, Marcel has held executive positions in drug development for Qu Biologicals and GT Biologics. Marcel received his PhD in Biotechnology from Wageningen University, where he published his thesis on "Whooping Cough vaccines: production of virulent biomass", in which he developed an improved chemically defined medium for Bordetella Pertussis.
Job Titles:
- Head of Fermentation and Lyophilization
Mattias De Coster, Head of Fermentation and Lyophilization. Mattias has 8 years hands-on fermentation experience in an R&D and scale up setting. Mattias started his career at Inbiose as fermentation engineer, tasked with the optimization of fed batch fermentations for the production of human milk oligosaccharides. Gradually gaining experience, Mattias became responsible for scale up from lab to pilot scale, guiding the process both practically and on paper, documenting the process and finalizing tech transfer documentation. Mattias performed his Masters thesis at Bio Base Europe Pilot Plant in Ghent, Belgium on scaled up production and Downstream Processing of specialty carbohydrates and has a MSc in biochemical engineering from the KU Leuven.
Sarah van Camp has a Bachelor's degree in Biomedical and pharmaceutical techniques. She brings over seven years of hands-on experience to her role as QC technician. Her experience spans a wide range of QC disciplines, including microbiology, PCR and residual moisture determination.
Łukasz Wajda obtained his PhD in Food Technology and Nutrition, followed by a 1 year post graduate position in molecular biology. Łukasz has 6 years of experience in R&D of probiotics, including developing of qPCR assays. Łukasz has experience in writing grant applications for development and the implementation of ISO9001 in a diagnostics setting. At BioLyo, Łukasz is one of our experts on statistics and fermentation.